Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

DBP International AB: Joint Venture agreement with Shijiazhuang Yuanjia Biotechnology for Temodex in China

Double Bond Pharmaceutical International AB (publ) via it's subsidiary Double Bond Pharmaceutical AB ("DBP", org. No. 556959-2982) has today signed an agreement with Shijiazhuang Yuanjia Biotechnology Co., Ltd  via it's subsidiary Shijiazhuang Yuanta Biotechnology Co., Ltd ("SYB") for setting up a joint venture in China for commercialization of Temodex in the Chinese market. Under the terms of the agreement DBP grants to the joint venture exclusive rights for the product for 25% of shares of the joint venture as well as €0.5 million of milestones payment conditioned by formal market

Serbian dinar — new currency at Conotoxia.com

Conotoxia.com web portal has added a new currency, the Serbian dinar (RSD) to its portfolio. In total, the offer now includes 28 currencies, from which 756 currency pairs can be formed.Conotoxia.com users can now exchange the Serbian dinar, as well as use it in money transfers and online payments. The offer is available for both individual and business customers.  "Taking into account the number of offered currencies, Conotoxia.com is one of the market leaders; and today we prove once again that we want to keep it that way. Interest in currencies outside the top 5 of our portfolio

Mentice Expands its Coronary Product Portfolio with an Advanced Software Solution for Coronary Interventions

Coronary Advanced to Help Fellows and Attending Interventional Cardiologists to Perfect Skills in Complex ScenariosMentice AB (STO: MNTC), a world leader in high-fidelity endovascular simulation introduces Coronary Advanced for select VIST® platforms. Following the introduction of Coronary Essentials and Coronary Intermediate, Coronary Advanced is the most sophisticated solution, specifically designed for advanced fellows and attending IC’s.    The solution was designed to take full advantage of the premium version of Mentice’s seventh generation VIST® platform, the VIST® G7+. This new

NetEnt on for another branded smash hit with Street Fighter II: The World Warrior Slot™

Iconic videogame collaboration joins supplier’s branded hall of fame NetEnt has transformed one of the best-selling arcade games of all time for online slot fans with the release of Street Fighter II: The World Warrior Slot™, featuring a cast of eight original characters ready for combat. In a new spin on the classic video game from Capcom™, the new 5-reel, 5-row Cluster Pays video slot emulates the battle mechanics of the original title by pitting the player’s chosen character against opponents and letting the reels decide which fighter is victorious. Winning combinations

Interim report 1 January – 31 March 2020

Scandion Oncology A/S (”Scandion Oncology” or ”the Company”) hereby publishes the interim report for the period January – March 2020. The interim report is available on the Company's website (www.scandiononcology.com). Below is a summary of the report.ReportingJanuary – March 2020 · Net sales amounted to DKK 0 (0). · Operating profit was -4.0 m DKK (-2.3). · Cash and bank assets amounted to 11.0 m DKK (5.3). · Result per share was DKK -0.20 (-0.26). · Equity ratio was 89 % (92). Highlights during the period · On January 13th, 2020 Scandion Oncology announced that

Operations update

EnQuest PLC, 21 May 2020 Operations update Strong production supports full year 2020 guidance with forecast free cash flow[1] breakeven unchanged at c.$33/Boe Strong production performance - Group production averaged 65,938 Boepd in the four months to end April 2020, above the top end of the Group's full year 2020 production guidance, which remains unchanged at between 57,000 Boepd to 63,000 Boepd - Group performance remains materially unaffected by COVID-19 - Kraken average gross production of c.38,000 Bopd, up c.36% year on year reflecting improved FPSO performance and

AstraZeneca advances response to global COVID-19 challenge as it receives first commitments for Oxford's potential new vaccine

This announcement contains inside information 21 May 2020 07:00 BST AstraZeneca advances response to global COVID-19 challenge as it receives first commitments for Oxford's potential new vaccine Company working on a number of agreements in parallel to ensure broad and equitable supply of the vaccine throughout the world at no profit during the pandemic   First agreements to supply at least 400 million doses; Company has total capacity sourced for one billion doses through 2020 and into 2021; continues to increase capacity further More than $1bn US BARDA investment to

AddSecure acquires Connexas to expand its Smart Transport footprint into the UK

With the strategic acquisition of Connexas Group in the UK, AddSecure expands its position as a leading Fleet and Transport Management solutions provider in Europe. AddSecure , a leading European provider of premium solutions for secure data and critical communications, today announced the acquisition of Connexas , a leading provider of fleet management solutions throughout the UK, EU, North America and Australia. With Connexas, AddSecure establishes a presence for transport and logistics, in the strategically important UK market,

Read original

Josemaria Annual General and Special Meeting of Shareholders to be Held June 16, 2020

VANCOUVER, May 20, 2020 /CNW/ – Josemaria Resources Inc. (“Josemaria” or the “Corporation”) (TSX: JOSE; NASDAQ Stockholm: JOSE), announces that its Annual General and Special Meeting of Shareholders (the “Meeting”) will be held at Suite 2000, 885 West Georgia Street, Vancouver, British Columbia, V6C 3E8 on Tuesday, June 16, 2020, at 10:00 a.m. (Pacific Daylight Time). SPECIAL NOTE REGARDING COVID-19 Due to the ongoing novel coronavirus disease pandemic (“COVID-19”) and the evolving restrictions on the size of public gatherings, which are beyond Josemaria’s control, the Corporation

Borr Drilling Limited – Contemplated Equity Offering of up to USD 30 Million

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, HONG KONG, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO BUY, SELL OR SUBSCRIBE FOR ANY SECURITIES DESCRIBED HEREIN. Hamilton, Bermuda, 20 May 2019 With reference to today’s trading update, Borr Drilling Limited (the “Company” or “Borr Drilling”) (NYSE: BORR, OSE: BDRILL) has been in discussions with the Company’s creditors and ship yards, in

Report from the annual general meeting of AlzeCure Pharma on 20 May 2020

Today, 20 May 2020, the annual general meeting was held in AlzeCure Pharma AB (publ). Below is a summary of the resolutions made. All resolutions were passed with the required majority.Resolution on the establishment of accounts and disposal of the company’s result The annual general meeting resolved to establish the income statement and the balance sheet. The annual general meeting also resolved to dispose the company’s result in accordance with the board of directors’ proposal, meaning that no dividend is paid to the shareholders, and that available funds are carried forward.

Trade subject to notification

On 4 March 2020, the Board of Directors of DNB ASA decided to offer employees in DNB ASA shares with a discount of 20 % (up to NOK 14,500 per employee). The shares were allotted today, 20 May 2020, at a gross price of NOK 117.5414 per share. Attached is a list of the primary insiders that availed themselves of the offer. This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Insr: Minutes from General Meeting held

Insr Insurance Group ASA today, May 20th, 2020, held an Annual General Meeting. All proposals to the General Meeting were approved as proposed by the Board of Directors. A new chairman was elected, Øystein Engebretsen, as well as two new board members, Dr Immo Querner and Nicklas Ward. The minutes from the General Meeting are attached and available on https://www.insr.io/investor-relations/.  For further information, please contact:  Anne B. Knudtzon, SVP Business Controlling & Investor Relations T: +47 926 10 606     E: anne.b.knudtzon@insr.io Partnership insurance

Tikkurila completes the repurchases of own shares

Tikkurila Oyj, Stock Exchange Release, May 20, 2020 at 19.30 EEST Tikkurila completes the repurchases of own shares As communicated on 18 May 2020, The Board of Directors decided to utilize the authorization given by the Annual General Meeting (AGM) held on April 11, 2019. The repurchases started on May 18, 2020 and ended on May 20, 2020. During this period, Tikkurila repurchased 17,000 shares, corresponding to about 0.04 per cent of the total number of shares and votes. The repurchased shares will primarily be used for implementing future share-based incentive programs of the

LED iBond publishes prospectus for its initial public offering in Copenhagen

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN. This announcement does not constitute a prospectus. No one should purchase or subscribe any securities in LED iBond International A/S (“LED iBond” or “the Company”) except on the basis of information in the prospectus published by the Company in connection with the offering and admission of such securities to trading and official listing on Nasdaq First North Growth Market in Denmark.· LED iBond offers a minimum of 3,633,721 and a

Updated SPARKLE timelines due to Covid-19 impact

Ascelia Pharma AB (publ) (ticker: ACE) (“Ascelia Pharma”) today announced updated timelines for the completion and top line results of the pivotal Phase 3 study SPARKLE with the lead compound Mangoral, which are now expected in H2 2021 instead of H1 2021 as previously communicated. The expected addition of three to six months reflects the impact of the Covid-19 pandemic.Ascelia Pharma is making good progress towards making Mangoral available to physicians and patients as a safe and effective imaging drug used in liver MRI for patients with severe kidney insufficiency or acute kidney injury.

Tikkurila Oyj acquisition of own shares 20.05.2020

Tikkurila Oyj, Stock exchange release, 20.05.2020 at 18.30 (EET/EEST)  Date 20.05.2020Exchange transaction BuyShare class TIK1VAmount       8,410Average price/share 12.6139 EURHighest price/share 12.8000 EURLowest price/share 12.1800 EURTotal price 106,082.90 EUR The shares held by Tikkurila Oyj on 20.05.2020: TIK1V  19,461 On behalf of Tikkurila Oyj  Skandinaviska Enskilda Banken AB (Publ)   Antti Salakka    Mikko Virtanen For more information, please contact: Markus Melkko

Wulff Group Plc starts to buy back its own shares

STOCK EXCHANGE RELEASE  20.5.2020 AT 5.30 P.M.  The Board of Directors of Wulff Group Plc has decided to start buy back its own shares in accordance with the authorization granted by the Annual General Meeting on April 23, 2020. The shares to be acquired are intended to be used to finance acquisitions and other arrangements according to the company´s growth strategy. The maximum number of shares to be repurchased is 70,000, which corresponds to approximately 1.01% of the total number of Wulff Group Plc shares. The shares will be acquired through public trading on NASDAQ OMX Helsinki,

Media invitation - demonstration of disinfecting robot to help nation get back to work

MEDIA INVITATION - demonstration of disinfecting robot to help nation get back to workForth Engineering DemonstrationSellafield Ltd officesDate: Friday, May 22Time: noon-3pmVenue: Whitehaven Civic HallLowther Street, Whitehaven, CA28 7SHParking: available in pay and display car-park at nearby Morrisons supermarket Contact at site: Jonathan Lee 07444 022038Please be advised social distancing regulations must be adhered to at all times. 15-minute time slots are available for a demonstration between noon and 3pmTo reserve a time slot contact Jonathan Lee at 32West by 2pm on

2020 All-Women DreamHack Showdown Announced

All-Women CS:GO Summer Tournament to Take Place Online, July 2020All-Women CS:GO Fall Tournament to Take Place Online in 2020STOCKHOLM — DreamHack , the premier gaming and digital lifestyle festival, has long been dedicated to the growth of professional gaming — not just for the very best players, but for those aspiring to become them. Following the success of the 2019 all-women DreamHack Showdown —featuring the renowned Counter-Strike: Global Offensive (CS:GO) — DreamHack has announced the 2020 DreamHack Showdown . The summer

Bulletin from the Annual General Meeting of Vicore Pharma Holding AB (publ)

The following resolutions were passed at the annual general meeting (the “AGM”) of Vicore Pharma Holding AB (publ) on 20 May 2020. Adoption of income statement and balance sheet for the financial year 2019 and discharge from liability The AGM resolved to adopt the income statement and the consolidated income statement for the financial year 2019 as well as the balance sheet and consolidated balance sheet as of 31 December 2019. The members of the board of directors and the managing director were discharged from liability for the financial year 2019. Allocation of profit or loss

Frill Holding AB publishes Annual Report 2019

STOCKHOLM, WED, May 20, 2020 16:45 CET   Frill Holding AB has today published its Annual Report for 2019 on the Company’s website: www.frillholding.com.About Frill Holding ABFrill is an innovative company that has developed a unique technology platform for frozen foods with its first products being Frill, a plant-based frozen dessert that is a genuinely healthy ice-cream made with whole fruit and vegetable, and Add ice-cream, a healthy ice cream that delivers functional benefits such as protein and vitamins. Frill creates healthy nutritional alternatives based on scientific evidence

The Finnish Financial Supervisory Authority has approved a supplement to the prospectus prepared for the combination of Outotec and the Metso Minerals Business

OUTOTEC OYJ  STOCK EXCHANGE RELEASE  MAY 20, 2020 at 5:30 PM The Finnish Financial Supervisory Authority has approved a supplement to the prospectus prepared for the combination of Outotec and the Metso Minerals Business The Finnish Financial Supervisory Authority has today on May 20, 2020, approved a supplement to the Finnish language demerger prospectus (the “Prospectus”) relating to the combination of Outotec Oyj (“Outotec”) and Metso Corporation’s (“Metso”) Minerals business (the “Metso Minerals Business”). The supplement relates to the stock exchange releases published by

Sedana Medical: Exercise of warrants in incentive program 2017/21

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that all warrants in the company's incentive program 2017/21 have been exercised by the warrant holders, leading to an increase in the number of shares and votes in the company by 310,149. Accordingly, the share capital is increased by approximately SEK 31,015. Through the exercise of the warrants, Sedana Medical’s CEO, CFO and CMO have increased their ownership in the company. Further, the mentioned senior executives have sold part of the shares subscribed in order to finance the exercise of the warrants and future tax effects

There are no items matching the current filter
There are no more items matching the current filter
Back to top